MDeyesMDeyes Once Daily Macular Defence is a new standard in macular care based on the comprehensive clinical research of the Age-Related Eye Disease Study 2 (AREDS 2)
The AREDS 2 clinical trail investigated several thousand participants over many years, updating the original AREDS study. The trial was conducted by the National Eye Institute in the United States, and the results were published in 2013
AREDS 2 indicated that antioxidant nutrients and zinc, together with lutein and zeaxanthin, help defend against free radical damage to the macular region and help support the protective macular pigment of the retina.
AREDS 2 also found in lowering Zinc to a daily dose of 25mg was just as effective as the original high dose of 80mg
Specifically developed in response to the AREDS 2 findings, The MDeyes Once Daily formula delivers:
* The precise ingredients and total daily amounts studied in the low zinc formula, in a convenient once daily capsule * The quality active ingredients FloraGLO Lutein and OPTISHARP Zeaxanthin used in the AREDS 2 clinical trial
MDeyes also features innovative packaging to assist patient compliance
MDeyes in Australian made and owned, and is specifically an Eye Care Professional only brand - it is not sold through pharmacy. It is competitively priced and available now for purchase through The Eyewear House |  |